Audit of Pain Scores Post Nasal Surgeries

A study was conducted to measure patients pain scores post nasal surgeries performed at both Emersons Green and Devizes Practice plus Hospital during the months of October and November 2024 Lignospan injection is commonly used in nasal surgeries as a local anaesthethic and decongestant prior to nasal surgical procedure. Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, thereby effecting local anesthetic action. Each lignospan cartridge is a 2.2ml solution for injection that contains 44mg of lidocaine hydrochloride and 27.5micograms of adrenaline so each 1 ml contains 20mg of lidocaine hydrochloride and 12.6micrograms of adrenaline (1:80,000) For normal healthy adults, the amount of lidocaine HCl administered should be kept below 500 mg, and in any case, should not exceed 7 mg/kg (3.2 mg/lb) of body weight) Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours LIGNOSPAN is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations Lidocaine should be used with caution in patients with severe shock or heart block. Lidocaine should also be used with caution in patients with impaired cardiovascular function. Local anaesthetic solutions containing a vasoconstrictor should be used with caution in areas of the body supplied by end arteries or having otherwise compromised blood supply. Patients with peripheral vascular disease and those with hypertensive vascular disease may exhibit exaggerated vasoconstrictor response. Ischemic injury (such as exfoliating or ulcerating lesions) or necrosis may result. Preparations containing a vasoconstrictor should be used with caution in patients during or following the administration of potent general anaesthetic agents, since cardiac arrhythmias may occur under such conditions.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-25
DOI
https://doi.org/10.5281/zenodo.15522977
Primary Topic
Dental Anxiety and Anesthesia Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Audit of Pain Scores Post Nasal Surgeries

Zenodo (CERN European Organization for Nuclear Research)
Dental Anxiety and Anesthesia Techniques
article

Audit of Pain Scores Post Nasal Surgeries

article en

Abstract

A study was conducted to measure patients pain scores post nasal surgeries performed at both Emersons Green and Devizes Practice plus Hospital during the months of October and November 2024 Lignospan injection is commonly used in nasal surgeries as a local anaesthethic and decongestant prior to nasal surgical procedure. Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, thereby effecting local anesthetic action. Each lignospan cartridge is a 2.2ml solution for injection that contains 44mg of lidocaine hydrochloride and 27.5micograms of adrenaline so each 1 ml contains 20mg of lidocaine hydrochloride and 12.6micrograms of adrenaline (1:80,000) For normal healthy adults, the amount of lidocaine HCl administered should be kept below 500 mg, and in any case, should not exceed 7 mg/kg (3.2 mg/lb) of body weight) Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours LIGNOSPAN is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations Lidocaine should be used with caution in patients with severe shock or heart block. Lidocaine should also be used with caution in patients with impaired cardiovascular function. Local anaesthetic solutions containing a vasoconstrictor should be used with caution in areas of the body supplied by end arteries or having otherwise compromised blood supply. Patients with peripheral vascular disease and those with hypertensive vascular disease may exhibit exaggerated vasoconstrictor response. Ischemic injury (such as exfoliating or ulcerating lesions) or necrosis may result. Preparations containing a vasoconstrictor should be used with caution in patients during or following the administration of potent general anaesthetic agents, since cardiac arrhythmias may occur under such conditions.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 42%
Dental Anxiety and Anesthesia Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Audit of Pain Scores Post Nasal Surgeries · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS